Coronavirus (COVID-19) resources

Atomoxetine for Attention Deficit Hyperactivity Disorder (ADHD) in children and adolescents

To determine the efficacy and safety of atomoxetine in the treatment of ADHD in children and adolescents.

This is a protocol.

Health topics:

Developmental, psychosocial & learning problems > Psychosocial problems > Attention deficit hyperactivity disorder (ADHD)

Share

Published:

18 April 2012

Authors:

Kallapiran GK, Mammen P, Tharyan P, Russell P

Primary Review Group:

Developmental, Psychosocial and Learning Problems Group

See the full Review on

the Cochrane Library

Print
PDF
Citation
Kallapiran GK, Mammen P, Tharyan P, Russell P. Atomoxetine for Attention Deficit Hyperactivity Disorder (ADHD) in children and adolescents. Cochrane Database of Systematic Reviews 2012, Issue 4. Art. No.: CD009804. DOI: 10.1002/14651858.CD009804